Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

Abroad (travel likely)Recruiting

Conditions

Cryoglobulinemic Vasculitis (CV) · Drug-induced Vasculitis · Eosinophilic Granulomatosis With Polyangiitis (EGPA) · IgA Vasculitis · Isolated Cutaneous Vasculitis · Granulomatosis With Polyangiitis (GPA) · Microscopic Polyangiitis (MPA) · Polyarteritis Nodosa (PAN) · Urticarial Vasculitis · Vasculitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of California, Los Angeles, Los Angeles, California, United States
Boston University School of Medicine, Boston, Massachusetts, United States
Mayo Clinic, Rochester, Minnesota, United States
Cleveland Clinic, Cleveland, Ohio, United States
Oregon Health & Science University, Portland, Oregon, United States
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Laura Cesar) · Laura.Cesar@Pennmedicine.upenn.edu
University of Utah, Salt Lake City, Utah, United States
University of Virginia, Charlottesville, Virginia, United States
Contact: Study coordinator (Lauren Kuhns) · lrk9t@uvahealth.org
St. Joseph's Healthcare, Hamilton, Ontario, Canada
Contact: Study coordinator (Sandra Messier) · smessier@stjoes.ca
University of Toronto Mount Sinai Hospital, Toronto, Ontario, Canada
Contact: Study coordinator (Nazrana Haq) · Nazrana.Haq@sinaihealth.ca

Study leads

Robert Micheletti, MD
Principal Investigator
University of Pennsylvania
Peter Grayson, MD, MSc
Principal Investigator
The National Institute of Arthritis and Musculoskeletal and Skin Diseases

View source on ClinicalTrials.gov